These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. iPS cell technology-based research for the treatment of diabetic nephropathy. Osafune K Semin Nephrol; 2012 Sep; 32(5):479-85. PubMed ID: 23062989 [TBL] [Abstract][Full Text] [Related]
23. Current Stem-Cell Approaches for the Treatment of Inherited Retinal Degenerations. Terrell D; Comander J Semin Ophthalmol; 2019; 34(4):287-292. PubMed ID: 31188052 [TBL] [Abstract][Full Text] [Related]
24. Human stem cell research and regenerative medicine--present and future. Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982 [TBL] [Abstract][Full Text] [Related]
25. The past, present, and future of retinal regeneration. Hyde DR; Reh TA Exp Eye Res; 2014 Jun; 123():105-6. PubMed ID: 24636836 [No Abstract] [Full Text] [Related]
26. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells. Zhang G; Zhang Y Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081 [TBL] [Abstract][Full Text] [Related]
27. [Utilization of the ES/iPS cell technology for hematopoietic stem cell transplantation]. Otsu M; Nakauchi H Nihon Rinsho; 2012 Apr; 70 Suppl 2():146-50. PubMed ID: 23133943 [No Abstract] [Full Text] [Related]
28. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic. Whiting P; Kerby J; Coffey P; da Cruz L; McKernan R Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140375. PubMed ID: 26416684 [TBL] [Abstract][Full Text] [Related]
29. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979 [TBL] [Abstract][Full Text] [Related]
33. Current applications of human pluripotent stem cells: possibilities and challenges. Ho PJ; Yen ML; Yet SF; Yen BL Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556 [TBL] [Abstract][Full Text] [Related]
35. Regenerative Medicine: Solution in Sight. Wang Q; Stern JH; Temple S Adv Exp Med Biol; 2016; 854():543-8. PubMed ID: 26427457 [TBL] [Abstract][Full Text] [Related]
36. Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium. Ouyang H; Goldberg JL; Chen S; Li W; Xu GT; Li W; Zhang K; Nussenblatt RB; Liu Y; Xie T; Chan CC; Zack DJ Int J Mol Sci; 2016 Mar; 17(3):415. PubMed ID: 27102165 [TBL] [Abstract][Full Text] [Related]
37. Survival of Transplanted Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Human Recipient for 22 Months. Shim SH; Kim G; Lee DR; Lee JE; Kwon HJ; Song WK JAMA Ophthalmol; 2017 Mar; 135(3):287-289. PubMed ID: 28196199 [No Abstract] [Full Text] [Related]
38. Current therapeutic developments in atrophic age-related macular degeneration. Hanus J; Zhao F; Wang S Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922 [TBL] [Abstract][Full Text] [Related]
39. Fundus autofluorescence in geographic atrophy: a review. Choudhry N; Giani A; Miller JW Semin Ophthalmol; 2010; 25(5-6):206-13. PubMed ID: 21091001 [TBL] [Abstract][Full Text] [Related]